Yeouido St. Mary's Hospital
8
2
2
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
0.0%
0 terminated/withdrawn out of 8 trials
100.0%
+13.4% vs industry average
25%
2 trials in Phase 3/4
0%
0 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (8)
A Phase 4 Clinical Trial to Evaluate the Efficacy and Safety of CANIUM Tab. in Acute Bronchitis Patients.
Role: collaborator
Calorie Restricted Dietary Intervention in Type 2 Diabetes Patients With Obesity for Remission
Role: lead
Remission of Type 2 Diabetes Via Calorie Restriction
Role: lead
Immunotherapy in Lymphoma
Role: collaborator
SGLT2 Inhibitors on Clinical Outcomes and Left Ventricular Remodeling in Type 2 Diabetic Patients with Acute Myocardial Infarction, a Prospective, Multi-center Registry Study
Role: collaborator
Cohort of Inflammatory Bowel Disease Patient in Yeouido St. Mary's Hospital
Role: lead
CathOlic Medical Center percutAneous Coronary inTervention Registry (COACT)
Role: collaborator
Use of Ibandronate in Diabetic Patients
Role: lead
All 8 trials loaded